Cramer Rosenthal Mcglynn LLC Lowers Stock Holdings in Itron, Inc. $ITRI

Cramer Rosenthal Mcglynn LLC cut its holdings in Itron, Inc. (NASDAQ:ITRI) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 171,156 shares of the scientific and technical instruments company’s stock after selling 52,356 shares during the period. Itron accounts for about 1.3% of Cramer Rosenthal Mcglynn LLC’s holdings, making the stock its 26th biggest position. Cramer Rosenthal Mcglynn LLC’s holdings in Itron were worth $21,319,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Campbell & CO Investment Adviser LLC acquired a new stake in Itron in the 3rd quarter worth about $1,300,000. Robeco Schweiz AG lifted its holdings in shares of Itron by 31.2% during the 3rd quarter. Robeco Schweiz AG now owns 372,176 shares of the scientific and technical instruments company’s stock worth $46,358,000 after acquiring an additional 88,504 shares during the period. Schroder Investment Management Group boosted its position in shares of Itron by 23.6% in the second quarter. Schroder Investment Management Group now owns 376,087 shares of the scientific and technical instruments company’s stock worth $49,504,000 after acquiring an additional 71,702 shares during the last quarter. J. Safra Sarasin Holding AG purchased a new stake in Itron in the third quarter valued at approximately $4,673,000. Finally, Envestnet Asset Management Inc. increased its position in Itron by 34.0% during the third quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock worth $18,474,000 after purchasing an additional 37,634 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Buying and Selling

In other news, SVP Donald L. Reeves III sold 519 shares of Itron stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $97.84, for a total transaction of $50,778.96. Following the sale, the senior vice president owned 29,951 shares in the company, valued at $2,930,405.84. This trade represents a 1.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Joan S. Hooper sold 3,533 shares of the business’s stock in a transaction on Thursday, February 26th. The stock was sold at an average price of $95.92, for a total transaction of $338,885.36. Following the transaction, the chief financial officer directly owned 118,275 shares in the company, valued at approximately $11,344,938. The trade was a 2.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 51,180 shares of company stock valued at $5,085,475 over the last three months. Company insiders own 1.45% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ITRI shares. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Wall Street Zen cut Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Oppenheimer boosted their price target on Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Guggenheim set a $155.00 price objective on Itron in a report on Friday, February 13th. Finally, Robert W. Baird set a $128.00 price objective on Itron and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Seven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Itron currently has an average rating of “Moderate Buy” and an average target price of $138.56.

Itron Trading Down 1.2%

NASDAQ:ITRI opened at $91.22 on Friday. The business’s 50-day moving average is $97.59 and its two-hundred day moving average is $108.21. The firm has a market capitalization of $4.10 billion, a PE ratio of 14.01, a price-to-earnings-growth ratio of 0.80 and a beta of 1.44. Itron, Inc. has a 12 month low of $88.57 and a 12 month high of $142.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.27. The company had revenue of $571.66 million during the quarter, compared to the consensus estimate of $561.31 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company’s revenue was down 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Research analysts predict that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.